| P50 | author | Harry Sokol | Q56382889 |
| | Rebeca Martín | Q57061138 |
| | Florian Chain | Q58227783 |
| | Monica Barone | Q88322891 |
| | Philippe Langella | Q114447036 |
| P2093 | author name string | Patrizia Brigidi | |
| | Luis G Bermúdez-Humarán | |
| P2860 | cites work | Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice | Q71472065 |
| | Actobiotics as a novel method for cytokine delivery | Q82515200 |
| | Animal models of inflammatory bowel disease | Q82786536 |
| | The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models | Q87087790 |
| | Next-generation probiotics: the spectrum from probiotics to live biotherapeutics | Q87909855 |
| | A review on chemical-induced inflammatory bowel disease models in rodents | Q26827500 |
| | A proposed framework for an appropriate evaluation scheme for microorganisms as novel foods with a health claim in Europe | Q27000702 |
| | Alternative activation of macrophages | Q27860939 |
| | Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens | Q28075653 |
| | Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 | Q28179431 |
| | Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | Q28241661 |
| | Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria | Q33787825 |
| | Alternative versus classical activation of macrophages. | Q33868142 |
| | Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group | Q33927770 |
| | How informative is the mouse for human gut microbiota research? | Q34818253 |
| | Gut ecosystem: how microbes help us. | Q35105266 |
| | Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model. | Q35336737 |
| | Interleukin-6 and chronic inflammation | Q35578869 |
| | Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis | Q35841124 |
| | Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota | Q36209737 |
| | Antibodies to interleukin 12 abrogate established experimental colitis in mice | Q36365464 |
| | New vistas on macrophage differentiation and activation | Q36689930 |
| | Probiotic bacteria: legislative framework-- requirements to evidence basis | Q36740898 |
| | TNF-mediated inflammatory disease. | Q37045764 |
| | Inflammatory bowel disease, past, present and future: lessons from animal models | Q37093634 |
| | Interleukin-2 in the development and control of inflammatory disease | Q37374918 |
| | IL-17 cytokines in immunity and inflammation | Q38514251 |
| | Using murine colitis models to analyze probiotics-host interactions. | Q40084224 |
| | Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. | Q41268129 |
| | Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes | Q41984821 |
| | Chemically induced mouse models of intestinal inflammation | Q42510602 |
| | Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses | Q42944018 |
| | IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis | Q43201345 |
| | IL-10 promotes production of intestinal mucus by suppressing protein misfolding and endoplasmic reticulum stress in goblet cells. | Q43796791 |
| | Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. | Q49073992 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 565 | |
| P577 | publication date | 2018-03-27 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain | |
| P478 | volume | 9 | |